Interpretation of reverse redistribution of 99mTc-tetrofosmin in patients with acute myocardial infarction

European Journal of Nuclear Medicine

Volumn 29, Issue 12, 2002, Pages 1594-1599

  Hirata, Yoshihide ^a,d   Takamiya, Michitaka ^a   Kinoshita, Noriyuki ^a   Yamada, Hiroyuki ^a   Shima, Takatomo ^a   Miyazaki, Hiroshi ^a   Kouno, Yoshio ^a   Sawada, Naohisa ^b   Sakamoto, Kenzou ^b   Sugihara, Hiroki ^c  

^a KYOTO FIRST RED CROSS HOSPITAL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c MATSUSHITA MEMORIAL HOSPITAL   (Japan)

^d NONE   (Japan)

Author keywords

99mTc tetrofosmin; Acute myocardial infarction; Direct PTCA; Reverse redistribution; Salvaged myocardium

Indexed keywords

TETROFOSMIN TC 99M; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; ECHOCARDIOGRAPHY; FEMALE; HEART CONTRACTION; HEART DISEASE; HEART VENTRICLE WALL MOTION; HUMAN; MALE; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING ORGAN SYSTEMS; CLINICAL TRIAL; ECHOGRAPHY; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART VENTRICLE; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; MIDDLE AGED; PREDICTION AND FORECASTING; SCINTISCANNING; SINGLE BLIND PROCEDURE; TISSUE DISTRIBUTION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; HEART VENTRICLE CONTRACTION; IMAGE DISPLAY; INCIDENCE;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SINGLE-BLIND METHOD; TISSUE DISTRIBUTION; TISSUE SURVIVAL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 1842847339     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-0968-1     Document Type: Article

References (19)

1. Tamaki N, Takahashi N, Kawamoto M, et al. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. J Nucl Med 1994; 35:594-600.
2. Jain D, Wackers FJT, Mattera J, Mcmahon M, Sinusas AJ, Zaret BL. Biokinetics of technetium-99m-tetrofosmin: Myocardial perfusion imaging agent: Implications for one day imaging protocol. J Nucl Med 1993; 34:1254-1259.
3. 201Tl imaging and coronary angiography in a phase multicenter trial. Circulation 1995; 91:313-319.
4. 201Tl myocardial scintigraphy. Kaku Igaku 1994; 31:309-318.
5. 99mTc tetrofosmin. Kaku Igaku 1997; 34:45-58.
6. Nakajima K, Taki J, Shuke N, Bunko H, Takata S, Hisada K. Myocardial perfusion imaging and dynamic analysis with technetium-99m-tetrofosmin. J Nucl Med 1993; 34:1478-1484.
7. Sugihara H, Taniguchi Y, Kinoshita N, et al. Reverse redistribution of Tc-99m-tetrofosmin in exercise myocardial SPECT in patients with hypertrophic cardiomyopathy. Ann Nucl Med 1998; 12:287-292.
8. Sugihara H, Kinoshita N, Adachi Y, et al. Early and delayed Tc-99m-tetrofosmin myocardial SPECT in patients with left bundle branch block. Ann Nucl Med 1998; 12:281-286.
9. Weiss AT, Maddahi J, Lew AS, et al. Reverse redistribution of thallium-201: A sign of nontransmural myocardial infarction with patency of the infarct-related coronary artery. J Am Coll Cardiol 1987; 7:331-336.
10. Biggi A, Farinelli M, Bruna C, Papaleo A, De Benedictis N, Camuzzini GF. Thallium-201 reverse redistribution at rest: A pattern of myocardial infarction. J Nucl Med Allied Sci 1987; 31:331-336.
11. Takeishi Y, Sukekawa H, Fujiwara S, Ikeno E, Sasaki Y, Tomoike H. Reverse redistribution of technetium-99m-sestamibi following direct PTCA in acute myocardial infarction. J Nucl Med 1996; 37:1289-1294.
12. Arii T, Naruse H, Sakaki T, Masai M, Takahashi K, Ohyanagi M, Iwasaki T, Fukuchi M. Reverse redistribution of technetium-99m-tetrofosmin after acute coronary revascularization in patients with myocardial infarction. J Cardiol 1999; 34:1-8.
13. Sugihara H, Tatsuya N, Yamashita E, Kinoshita N, Ito K, Azuma A, Okuyama C, Ushijima Y, Nakagawa M, Maeda T. Reverse redistribution of Tc-99m-tetrofosmin in patients with acute myocardial infarction. Ann Nucl Med 1999; 13:43-47.
14. Sridhara BS, Braat S, Rigo P, et al. Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease. Am J Cardiol 1993; 72:1015-1019.
15. Platts EA, North TL, Pickett RD, Kelly JD. Mechanism of uptake of technetium-tetrofosmin. I. Uptake into isolated adult rat ventricular myocytes and subcellular localization. J Nucl Cardiol 1995; 2:317-326.
16. Younes A, Songadele JA, Maublant J, Platts E, Pickett R, Veyre A. Mechanism of uptake of technetium-tetrofosmin: Uptake into isolated adult rat heart mitochondria. J Nucl Cardiol 1995; 2:327-333.
17. Arbab AS, Koizumi K, Toyama K, Arai T, Araki T. Technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells. J Nucl Med 1998; 39:266-271.
18. Nakamura K, Sammya T, Hashimoto J, Ishibasi R, Matsumoto K, Kubo A. Comparison of cationic myocardial perfusion agents: Characteristics of accumulation in cultured smooth muscle cells. Ann Nucl Med 1996; 10:375-381.
19. Fujiwara S, Takeishi Y, Atsumi H, et al. Prediction of functional recovery in acute myocardial infarction: Comparison between sestamibi reverse redistribution and sestamibi/BMIPP mismatch. J Nucl Cardiol 1998; 5:119-127.